Arkolith/Insider Trading/BLTE/Form 4

Mata Nathan L.

Chief Scientific OfficerBELITE BIO, INC (BLTE) · full profile →Form 4 · filed Apr 30, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$156K
Net Open-Market Flow
-$156K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 29, 2026Sell(S)278$154.58$43K6K
Apr 29, 2026Sell(S)259$155.52$40K6K
Apr 29, 2026Sell(S)339$156.43$53K6K
Apr 29, 2026Sell(S)102$157.39$16K6K
Apr 29, 2026Sell(S)22$158.19$3K6K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-197320) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML